NorthMarq Capital arranges acquisition financing of $10.5 million for KBI Biopharma in Durham, North Carolina

KBI Biopharma
e5e259a3-b9f3-41f9-b90b-1a67210d1746.jpg
MIAMI (October 5, 2014) – Jeff Robertson, senior vice president/managing director of NorthMarq Capital’s Miami office arranged acquisition finaning of $10.5 million for KBI Biopharma, a property with five flex-industrial buildings containing a combined 341,298 sq.ft. The property is located at 1101 Hamlin Road in Durham, North Carolina. The transaction was structured with a 3-year term and 25-year amortization schedule and was arranged by NorthMarq for the borrower through its relationship with a regional bank.

Northmarq is a full-service capital markets resource for commercial real estate investors, offering seamless collaboration with top experts in debt, equity, investment sales, loan servicing, and fund management. The company combines industry-leading capabilities with a flexible structure, enabling its national team of experienced professionals to create innovative solutions for clients. Northmarq’s solid foundation and entrepreneurial approach have built a loan servicing portfolio of more than $76 billion and a two-year transaction volume of more than $52 billion. Through the 2022 acquisition of Stan Johnson Company, Northmarq established itself as a provider of opportunities across all major asset classes. For more information, visit www.northmarq.com.